Skip to main content
Clinical Trials/NCT03191513
NCT03191513CompletedNot Applicable

The Acute Effects of Interesterification of Commercially Used Fats on Postprandial Fat Metabolism

King's College London1 site in 1 country24 target enrollmentStarted: June 12, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
24
Locations
1
Primary Endpoint
Area under plasma TAG concentration/ time curve

Study Overview

Brief Summary

The purpose of this study is to investigate whether there are differences in postprandial metabolic indices following interesterified fats used commercially versus the corresponding un-interesterified blend.

Detailed Description

Aim: The current study aims to investigate the acute effects of commercially relevant interesterified 'hardstock' versus the corresponding un-interesterified blend on 8 h postprandial fat metabolism.

Hypothesis

Interesterification of a palm kernel and palm stearin fat blend, to produce a fat with a higher proportion of palmitic acid in the middle position of the triglyceride (TAG; but the same fatty acid composition), will alter postprandial lipid metabolism.

Subjects: Participants will include 24 healthy male and female (postmenopausal) volunteers aged between the ages of 45 and 75 years (since during this age metabolic changes start to take place).

Power calculation: Based on previous studies carried out by our group at King's College London, a sample size of 10 males and 10 females is required to detect a (clinically relevant) difference (for males and females separately) between means of 0.3 mmol/L maximal difference in 8 h plasma TAG concentration (standard deviation 0.33 mmol/L, significance level (alpha) of 0.05 and 80% power). 12 males and 12 females will be recruited to allow for a 20% drop out rate.

Expected value:The study will provide novel information on the acute effects of commercially relevant processed fats on postprandial lipaemia.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
45 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Males and females aged 45-75 years
  • •Healthy (free of diagnosed diseases listed in

Exclusion Criteria

  • •Able to understand the information sheet and willing to comply with study protocol
  • •Able to give informed consent
  • •Exclusion Criteria:
  • •Medical history of myocardial infarction, angina, thrombosis, stroke, cancer, liver or bowel disease or diabetes
  • •Body mass index < 20 kg/m2 or > 35 kg/m2
  • •Plasma cholesterol ≥7.5 mmol/L
  • •Plasma triacylglycerol > 3 mmol/L
  • •Plasma glucose > 7 mmol/L
  • •Blood pressure ≥140/90 mmHg
  • •Current use of antihypertensive or lipid lowering medications
  • •Premenopausal (for women)
  • •Alcohol intake exceeding a moderate intake (> 28 units per week)
  • •Current cigarette smoker (or quit withint the last 6 months)
  • •≥ 20% 10-year risk of CVD as calculated using a risk calculator

Arms & Interventions

Control

Active Comparator

Rapeseed oil. 50g fat.

Intervention: Rapeseed oil (Dietary Supplement)

Interesterified

Experimental

Interesterified blend of palm kernal and plam stearin. 50g fat.

Intervention: Interesterified blend of palm kernal and plam stearin (Dietary Supplement)

Un-interesterified

Active Comparator

Un-interesterified blend of palm kernal and plam stearin. 50g fat.

Intervention: Un-interesterified blend of palm kernal and plam stearin (Dietary Supplement)

Outcomes

Primary Outcomes

Area under plasma TAG concentration/ time curve

Time Frame: Up to 8 hours

Postprandial area under plasma TAG concentration/ time curve

Secondary Outcomes

  • Positional composition retention (chylomicron)(Up to 6 hours)
  • Postprandial lipaemic response(Up to 8 hours)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials